Lifeline Biotechnologies Inc (LLBO)

[confirm]

Dodge- my PPS was based on Cyrcadia Health grabbing *10% of USA 40Mill plus Mammogram market for in home breast screening...Cyrcadia expects 12 annual screenings to cost ~~$200-250 annual total, But I only used $150/annual fee for my Revenue (as they had stated the initial screening cost will eventually fall)
So annual Rev projection of $600Mill {40Mx10%=4Mx150=600M},, which is “only” the USA.
My PPS was based on EBITDA & I believe ~~40-45% margin!

((Past post.... EBITDA profit of 45% =
about $270,000,000M
Value “Cyrcadia Health” at 5X (std for EBITDA valuation) that profit =(270mil x 5= $1.5 Billion), So
LLBO PPS fair value (LLBO owns 30% of Cyrcadia or $450 Million-30% of 1.5Bill Cyrcadia Health valuation)
so ...LLBO has 3.1 Bill OS,
(450M/3.1B =$.145 PPS)

*Don’t like 10% mkt share adjust accordingly, add world sales in (Cyrcadia Asia separate, but will help drive down Mfg & annual product cost as well as annual screening cost through data center usage), etc.